Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study
暂无分享,去创建一个
Smitha Shankar | Gerhard Walzl | Stefan H E Kaufmann | David G. Sterling | Nebojsa Janjic | Daniel E. Zak | Thomas Hraha | D. Zak | S. Kaufmann | N. Janjić | M. Hatherill | T. Scriba | W. Hanekom | S. Suliman | G. Walzl | U. Ochsner | J. Sutherland | T. Hraha | S. Mbandi | Mark Hatherill | Stanley Kimbung Mbandi | Adam Penn-Nicholson | Ethan G Thompson | David Sterling | Kirsten M Wall | Michelle Fisher | Sara Suliman | Willem A Hanekom | Jayne Sutherland | Mary Ann De Groote | Urs Ochsner | Daniel E Zak | Thomas J Scriba | A. Penn-Nicholson | M. A. De Groote | E. Thompson | Michelle Fisher | K. Wall | Smitha Shankar | S. K. Mbandi
[1] M. Behr,et al. Revisiting the timetable of tuberculosis , 2018, British Medical Journal.
[2] H. Randeva,et al. Metformin increases the novel adipokine cartonectin/CTRP3 in women with polycystic ovary syndrome. , 2013, The Journal of clinical endocrinology and metabolism.
[3] Purvesh Khatri,et al. Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis. , 2016, The Lancet. Respiratory medicine.
[4] R. Diel,et al. Predictive value of interferon-γ release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis. , 2012, Chest.
[5] G. A. Mack,et al. K-Sample Rank Tests for Umbrella Alternatives , 1981 .
[6] Daniel E. Zak,et al. A prospective blood RNA signature for tuberculosis disease risk , 2016, The Lancet.
[7] John L. Johnson,et al. Elucidating Novel Serum Biomarkers Associated with Pulmonary Tuberculosis Treatment , 2013, PloS one.
[8] Daniel E. Zak,et al. Four‐Gene Pan‐African Blood Signature Predicts Progression to Tuberculosis , 2018, American journal of respiratory and critical care medicine.
[9] Mark R Segal,et al. Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients With Stable Coronary Heart Disease. , 2016, JAMA.
[10] M. Katoh. Multi-layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β-catenin signaling activation (Review) , 2018, International journal of molecular medicine.
[11] G. Kaplan,et al. Metformin as adjunct antituberculosis therapy , 2014, Science Translational Medicine.
[12] M. Pai,et al. Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. , 2012, The Lancet. Infectious diseases.
[13] P. Drain,et al. Diagnostic accuracy of C-reactive protein for active pulmonary tuberculosis: a meta-analysis. , 2017, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[14] Peter J Dodd,et al. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling , 2016, PLoS medicine.
[15] J. Schölmerich,et al. The adiponectin paralog CORS‐26 has anti‐inflammatory properties and is produced by human monocytic cells , 2005, FEBS letters.
[16] S. Kaufmann,et al. Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB , 2016, Thorax.
[17] A. Schäffler,et al. C1q/TNF-related protein-3 (CTRP-3) attenuates lipopolysaccharide (LPS)-induced systemic inflammation and adipose tissue Erk-1/-2 phosphorylation in mice in vivo. , 2014, Biochemical and biophysical research communications.
[18] D. Sherman,et al. Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection , 2018, Clinical Microbiology Reviews.
[19] S. Kaufmann,et al. Ten challenges for TB biomarkers. , 2012, Tuberculosis.
[20] P. Lønning,et al. The insulin-like growth factor system in human immunodeficiency virus infection: relations to immunological parameters, disease progression, and antiretroviral therapy. , 2001, The Journal of clinical endocrinology and metabolism.
[21] G. Leung,et al. Lower risk of tuberculosis in obesity. , 2007, Archives of internal medicine.
[22] J. Schölmerich,et al. C1q/TNF-related protein-3 represents a novel and endogenous lipopolysaccharide antagonist of the adipose tissue. , 2010, Endocrinology.
[23] John L. Johnson,et al. Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis. , 2014, Tuberculosis.
[24] John L. Johnson,et al. Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease , 2017, PLoS pathogens.
[25] M. Hattori,et al. CTRP3 plays an important role in the development of collagen-induced arthritis in mice. , 2014, Biochemical and biophysical research communications.
[26] Jason A. Skinner,et al. Prospective Discrimination of Controllers From Progressors Early After Low-Dose Mycobacterium tuberculosis Infection of Cynomolgus Macaques using Blood RNA Signatures , 2018, The Journal of infectious diseases.
[27] M. Hatherill,et al. Predictive factors for latent tuberculosis infection among adolescents in a high-burden area in South Africa. , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[28] David G. Sterling,et al. Discovery and Validation of a Six-Marker Serum Protein Signature for the Diagnosis of Active Pulmonary Tuberculosis , 2017, Journal of Clinical Microbiology.
[29] Gerard Tromp,et al. Host blood RNA signatures predict the outcome of tuberculosis treatment , 2017, Tuberculosis.
[30] Virginia Pascual,et al. An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis , 2010, Nature.
[31] Fergal J. Duffy,et al. A Serum Circulating miRNA Signature for Short-Term Risk of Progression to Active Tuberculosis Among Household Contacts , 2018, Front. Immunol..
[32] M. Tameris,et al. TB Incidence in an Adolescent Cohort in South Africa , 2013, PloS one.
[33] S. Horswell,et al. Complement pathway gene activation and rising circulating immune complexes characterize early disease in HIV-associated tuberculosis , 2018, Proceedings of the National Academy of Sciences.
[34] Hsien-Ho Lin,et al. Association of Obesity, Diabetes, and Risk of Tuberculosis: Two Population-Based Cohorts , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[35] T. Magnuson,et al. Lower Circulating C1q/TNF-Related Protein-3 (CTRP3) Levels Are Associated with Obesity: A Cross-Sectional Study , 2015, PloS one.
[36] J. Schreiber,et al. Regulation of Adhesion by Flexible Ectodomains of IgCAMs , 2013, Neurochemical Research.
[37] D. Dowdy,et al. Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study , 2017, The Lancet. Infectious diseases.